{"address1": "6200 Lookout Road", "city": "Boulder", "state": "CO", "zip": "80301", "country": "United States", "phone": "720 647 8519", "website": "https://www.enliventherapeutics.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Enliven Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule inhibitors to help patients with cancer. The company's lead product candidates comprise ELVN-001, a small molecule kinase inhibitor which is in Phase 1 clinical trial to treat adults with chronic myeloid leukemia; and ELVN-002, a CNS penetrant and irreversible HER2 inhibitor that is in Phase 1 clinical trial for the treatment of non-small cell lung cancer (NSCLC) and other HER2 driven cancers and solid tumors. The company is headquartered in Boulder, Colorado.", "fullTimeEmployees": 62, "companyOfficers": [{"maxAge": 1, "name": "Mr. Samuel S. Kintz M.B.A.", "age": 38, "title": "Co-Founder, CEO, Secretary & Director", "yearBorn": 1986, "fiscalYear": 2023, "totalPay": 866409, "exercisedValue": 0, "unexercisedValue": 6852044}, {"maxAge": 1, "name": "Dr. Joseph P. Lyssikatos Ph.D.", "age": 59, "title": "Co-Founder & Chief Scientific Officer", "yearBorn": 1965, "fiscalYear": 2023, "totalPay": 632673, "exercisedValue": 0, "unexercisedValue": 4161155}, {"maxAge": 1, "name": "Dr. Helen Louise Collins M.D.", "age": 61, "title": "Chief Medical Officer", "yearBorn": 1963, "fiscalYear": 2023, "totalPay": 686192, "exercisedValue": 0, "unexercisedValue": 2038291}, {"maxAge": 1, "name": "Mr. Anish  Patel Pharm.D.", "age": 43, "title": "Co-Founder & COO", "yearBorn": 1981, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Benjamin  Hohl", "age": 34, "title": "CFO & Head of Corporate Development", "yearBorn": 1990, "fiscalYear": 2023, "totalPay": 488500, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Galya D. Blachman Esq., Ph.D.", "age": 46, "title": "Chief Legal Officer & Head of Business Development", "yearBorn": 1978, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 8, "boardRisk": 6, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 8, "governanceEpochDate": 1743465600, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 19.68, "open": 19.38, "dayLow": 18.355, "dayHigh": 19.625, "regularMarketPreviousClose": 19.68, "regularMarketOpen": 19.38, "regularMarketDayLow": 18.355, "regularMarketDayHigh": 19.625, "payoutRatio": 0.0, "beta": 1.146, "forwardPE": -7.9662447, "volume": 246012, "regularMarketVolume": 246012, "averageVolume": 238236, "averageVolume10days": 276470, "averageDailyVolume10Day": 276470, "bid": 18.73, "ask": 19.0, "bidSize": 1, "askSize": 1, "marketCap": 925203008, "fiftyTwoWeekLow": 15.96, "fiftyTwoWeekHigh": 30.03, "fiftyDayAverage": 21.1856, "twoHundredDayAverage": 23.454176, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 611763520, "profitMargins": 0.0, "floatShares": 26927441, "sharesOutstanding": 49004400, "sharesShort": 7335188, "sharesShortPriorMonth": 7442501, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.1497, "heldPercentInsiders": 0.06421, "heldPercentInstitutions": 1.02643, "shortRatio": 35.28, "shortPercentOfFloat": 0.35169998, "impliedSharesOutstanding": 52465600, "bookValue": 6.332, "priceToBook": 2.9816804, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -89024000, "trailingEps": -1.89, "forwardEps": -2.37, "enterpriseToEbitda": -5.869, "52WeekChange": 0.015599728, "SandP52WeekChange": 0.08089435, "quoteType": "EQUITY", "currentPrice": 18.88, "targetHighPrice": 42.0, "targetLowPrice": 33.0, "targetMeanPrice": 38.14286, "targetMedianPrice": 39.0, "recommendationMean": 1.125, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 7, "totalCash": 313440000, "totalCashPerShare": 6.396, "ebitda": -104237000, "totalDebt": 0, "quickRatio": 19.695, "currentRatio": 19.989, "returnOnAssets": -0.21869, "returnOnEquity": -0.32037, "freeCashflow": -46227248, "operatingCashflow": -73192000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "ELVN", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Enliven Therapeutics, Inc.", "longName": "Enliven Therapeutics, Inc.", "preMarketChange": -0.5699997, "preMarketChangePercent": -3.0190663, "preMarketPrice": 18.31, "regularMarketChange": -0.80000114, "regularMarketDayRange": "18.355 - 19.625", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 238236, "fiftyTwoWeekLowChange": 2.9199991, "fiftyTwoWeekLowChangePercent": 0.18295734, "fiftyTwoWeekRange": "15.96 - 30.03", "fiftyTwoWeekHighChange": -11.150002, "fiftyTwoWeekHighChangePercent": -0.37129542, "fiftyTwoWeekChangePercent": 1.5599728, "earningsTimestamp": 1741896302, "earningsTimestampStart": 1747047540, "earningsTimestampEnd": 1747396800, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.89, "epsForward": -2.37, "epsCurrentYear": -2.14, "priceEpsCurrentYear": -8.822429, "fiftyDayAverageChange": -2.3056011, "fiftyDayAverageChangePercent": -0.108828686, "twoHundredDayAverageChange": -4.574177, "twoHundredDayAverageChangePercent": -0.19502611, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.1 - Strong Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1584019800000, "regularMarketChangePercent": -4.0650463, "regularMarketPrice": 18.88, "corporateActions": [], "preMarketTime": 1743581528, "regularMarketTime": 1743537601, "exchange": "NMS", "messageBoardId": "finmb_693128628", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "marketState": "PRE", "displayName": "Enliven Therapeutics", "trailingPegRatio": null}